Gabelli Capex To Revenue vs Days Sales Outstanding Analysis

GRX Stock

USD 10.14 0.04 0.40%

Gabelli Healthcare financial indicator trend analysis is much more than just examining Gabelli Healthcare latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Gabelli Healthcare is a good investment. Please check the relationship between Gabelli Healthcare Capex To Revenue and its Days Sales Outstanding accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Gabelli Healthcare WellnessRx. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

Capex To Revenue vs Days Sales Outstanding

Capex To Revenue vs Days Sales Outstanding Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Gabelli Healthcare Capex To Revenue account and Days Sales Outstanding. At this time, the significance of the direction appears to have pay attention.

The correlation between Gabelli Healthcare's Capex To Revenue and Days Sales Outstanding is -0.84. Overlapping area represents the amount of variation of Capex To Revenue that can explain the historical movement of Days Sales Outstanding in the same time period over historical financial statements of Gabelli Healthcare WellnessRx, assuming nothing else is changed. The correlation between historical values of Gabelli Healthcare's Capex To Revenue and Days Sales Outstanding is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Capex To Revenue of Gabelli Healthcare WellnessRx are associated (or correlated) with its Days Sales Outstanding. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Days Sales Outstanding has no effect on the direction of Capex To Revenue i.e., Gabelli Healthcare's Capex To Revenue and Days Sales Outstanding go up and down completely randomly.

Correlation Coefficient

-0.84

Relationship Direction	Negative
Relationship Strength	Significant

View All Relationships

Capex To Revenue

The ratio of a company's capital expenditures to its total revenue, indicating how much of the revenue is used for acquiring or maintaining physical assets.

Days Sales Outstanding

Most indicators from Gabelli Healthcare's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Gabelli Healthcare current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Gabelli Healthcare WellnessRx. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

At this time, Gabelli Healthcare's Selling General Administrative is fairly stable compared to the past year. Sales General And Administrative To Revenue is likely to rise to 0.55 in 2024, whereas Issuance Of Capital Stock is likely to drop slightly above 11.4 M in 2024.

	2021	2022	2023	2024 (projected)
Depreciation And Amortization	236.6K	228.5K	167.9K	192.5K
Interest Income	45.0M	462.2K	636.6K	604.8K

Depreciation And Amortization Interest Income

Gabelli Healthcare fundamental ratios Correlations

	Total Assets	Total Stockholder Equity	Net Tangible Assets	Retained Earnings	Accounts Payable	Cash	Other Assets	Net Receivables	Other Stockholder Equity	Total Liab	Long Term Investments	Common Stock Shares Outstanding	Other Current Liab	Total Current Liabilities	Non Current Assets Total	Non Currrent Assets Other	Common Stock Total Equity	Total Current Assets	Short Term Debt	Common Stock	Short Long Term Debt Total	Net Debt	Cash And Short Term Investments	Non Current Liabilities Total	Net Invested Capital	Capital Stock
Total Assets		0.91	-0.73	0.19	0.11	0.18	-0.17	0.34	0.78	0.09	1.0	0.89	-0.26	0.26	0.33	-0.35	0.01	-0.31	0.31	0.02	0.16	-0.1	0.18	-0.13	0.35	0.0
Total Stockholder Equity	0.91		-0.59	-0.15	-0.21	-0.11	-0.31	0.42	0.83	-0.28	0.91	0.84	0.07	-0.07	0.34	-0.35	0.32	-0.32	0.32	0.33	-0.22	-0.3	-0.11	-0.32	0.25	0.37
Net Tangible Assets	-0.73	-0.59		-0.29	0.16	0.01	-0.47	-0.17	-0.64	-0.34	-0.73	-0.85	-0.02	0.02	0.34	-0.31	0.47	-0.18	0.17	0.47	-0.35	-0.38	0.0	-0.44	0.16	0.4
Retained Earnings	0.19	-0.15	-0.29		0.64	0.59	0.22	-0.42	-0.33	0.65	0.21	0.25	-0.67	0.67	-0.05	0.03	-0.79	-0.31	0.13	-0.77	0.9	0.63	0.59	0.42	0.51	-0.75
Accounts Payable	0.11	-0.21	0.16	0.64		0.86	-0.3	0.01	-0.23	0.54	0.11	-0.1	-0.99	0.99	0.39	-0.39	-0.27	-0.28	0.21	-0.29	0.61	0.08	0.86	-0.06	0.57	-0.51
Cash	0.18	-0.11	0.01	0.59	0.86		-0.26	0.08	-0.13	0.61	0.18	0.06	-0.87	0.87	0.21	-0.2	-0.29	-0.25	0.21	-0.34	0.59	0.14	1.0	-0.21	0.32	-0.49
Other Assets	-0.17	-0.31	-0.47	0.22	-0.3	-0.26		-0.42	-0.12	0.55	-0.16	0.02	0.29	-0.29	-0.7	0.62	-0.74	0.58	-0.4	-0.75	0.45	0.55	-0.26	0.85	-0.54	-0.61
Net Receivables	0.34	0.42	-0.17	-0.42	0.01	0.08	-0.42		0.67	-0.37	0.31	0.28	-0.07	0.07	-0.01	0.07	0.43	0.37	-0.25	0.41	-0.41	-0.16	0.08	-0.25	-0.12	0.19
Other Stockholder Equity	0.78	0.83	-0.64	-0.33	-0.23	-0.13	-0.12	0.67		-0.18	0.77	0.65	0.11	-0.11	0.16	-0.13	0.3	0.15	0.09	0.29	-0.22	-0.18	-0.12	-0.16	-0.07	0.21
Total Liab	0.09	-0.28	-0.34	0.65	0.54	0.61	0.55	-0.37	-0.18		0.1	0.05	-0.56	0.56	-0.17	0.11	-0.77	0.13	-0.02	-0.81	0.87	0.38	0.61	0.44	-0.07	-0.84
Long Term Investments	1.0	0.91	-0.73	0.21	0.11	0.18	-0.16	0.31	0.77	0.1		0.89	-0.26	0.26	0.34	-0.36	0.0	-0.33	0.32	0.0	0.18	-0.1	0.18	-0.13	0.36	0.0
Common Stock Shares Outstanding	0.89	0.84	-0.85	0.25	-0.1	0.06	0.02	0.28	0.65	0.05	0.89		-0.06	0.06	-0.05	0.03	-0.18	-0.19	0.03	-0.17	0.14	0.11	0.06	0.07	0.15	-0.08
Other Current Liab	-0.26	0.07	-0.02	-0.67	-0.99	-0.87	0.29	-0.07	0.11	-0.56	-0.26	-0.06		-1.0	-0.38	0.38	0.3	0.29	-0.2	0.31	-0.64	-0.11	-0.87	0.05	-0.58	0.54
Total Current Liabilities	0.26	-0.07	0.02	0.67	0.99	0.87	-0.29	0.07	-0.11	0.56	0.26	0.06	-1.0		0.38	-0.38	-0.3	-0.29	0.2	-0.31	0.64	0.11	0.87	-0.05	0.58	-0.54
Non Current Assets Total	0.33	0.34	0.34	-0.05	0.39	0.21	-0.7	-0.01	0.16	-0.17	0.34	-0.05	-0.38	0.38		-0.98	0.56	-0.7	0.78	0.57	-0.1	-0.61	0.21	-0.67	0.71	0.46
Non Currrent Assets Other	-0.35	-0.35	-0.31	0.03	-0.39	-0.2	0.62	0.07	-0.13	0.11	-0.36	0.03	0.38	-0.38	-0.98		-0.5	0.68	-0.79	-0.5	0.05	0.62	-0.2	0.61	-0.71	-0.42
Common Stock Total Equity	0.01	0.32	0.47	-0.79	-0.27	-0.29	-0.74	0.43	0.3	-0.77	0.0	-0.18	0.3	-0.3	0.56	-0.5		-0.24	0.27	1.0	-0.86	-0.8	-0.29	-0.81	0.06	0.92
Total Current Assets	-0.31	-0.32	-0.18	-0.31	-0.28	-0.25	0.58	0.37	0.15	0.13	-0.33	-0.19	0.29	-0.29	-0.7	0.68	-0.24		-0.67	-0.27	-0.04	0.33	-0.25	0.57	-0.72	-0.36
Short Term Debt	0.31	0.32	0.17	0.13	0.21	0.21	-0.4	-0.25	0.09	-0.02	0.32	0.03	-0.2	0.2	0.78	-0.79	0.27	-0.67		0.27	0.15	-0.22	0.21	-0.51	0.65	0.33
Common Stock	0.02	0.33	0.47	-0.77	-0.29	-0.34	-0.75	0.41	0.29	-0.81	0.0	-0.17	0.31	-0.31	0.57	-0.5	1.0	-0.27	0.27		-0.86	-0.77	-0.34	-0.79	0.1	0.93
Short Long Term Debt Total	0.16	-0.22	-0.35	0.9	0.61	0.59	0.45	-0.41	-0.22	0.87	0.18	0.14	-0.64	0.64	-0.1	0.05	-0.86	-0.04	0.15	-0.86		0.65	0.59	0.53	0.3	-0.88
Net Debt	-0.1	-0.3	-0.38	0.63	0.08	0.14	0.55	-0.16	-0.18	0.38	-0.1	0.11	-0.11	0.11	-0.61	0.62	-0.8	0.33	-0.22	-0.77	0.65		0.15	0.72	-0.02	-0.72
Cash And Short Term Investments	0.18	-0.11	0.0	0.59	0.86	1.0	-0.26	0.08	-0.12	0.61	0.18	0.06	-0.87	0.87	0.21	-0.2	-0.29	-0.25	0.21	-0.34	0.59	0.15		-0.21	0.32	-0.49
Non Current Liabilities Total	-0.13	-0.32	-0.44	0.42	-0.06	-0.21	0.85	-0.25	-0.16	0.44	-0.13	0.07	0.05	-0.05	-0.67	0.61	-0.81	0.57	-0.51	-0.79	0.53	0.72	-0.21		-0.23	-0.74
Net Invested Capital	0.35	0.25	0.16	0.51	0.57	0.32	-0.54	-0.12	-0.07	-0.07	0.36	0.15	-0.58	0.58	0.71	-0.71	0.06	-0.72	0.65	0.1	0.3	-0.02	0.32	-0.23		0.04
Capital Stock	0.0	0.37	0.4	-0.75	-0.51	-0.49	-0.61	0.19	0.21	-0.84	0.0	-0.08	0.54	-0.54	0.46	-0.42	0.92	-0.36	0.33	0.93	-0.88	-0.72	-0.49	-0.74	0.04

Click cells to compare fundamentals

Gabelli Healthcare Account Relationship Matchups

Gabelli Healthcare fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	307.0M	286.5M	350.8M	248.7M	239.0M	260.1M
Total Stockholder Equity	305.8M	242.2M	264.0M	204.7M	184.8M	231.4M
Retained Earnings	99.6M	110.9M	137.1M	79.5M	70.5M	66.5M
Accounts Payable	570.9K	3.6M	6.2M	3.5M	31.8K	30.2K
Other Assets	111.8K	67.3K	145.0K	159.2K	239.0M	251.0M
Net Receivables	378.9K	5.1M	476K	6.6M	772.3K	733.6K
Total Liab	570.9K	3.6M	86.9M	44.0M	54.2M	56.9M
Long Term Investments	306.5M	281.3M	350.2M	241.9M	238.1M	257.6M
Common Stock Shares Outstanding	18.4M	17.5M	17.2M	17.0M	16.0M	18.0M
Other Current Liab	(570.9K)	(3.6M)	(6.2M)	(3.5M)	(384.0)	(403.2)
Total Current Liabilities	570.9K	3.6M	6.2M	3.5M	384.0	364.8
Non Current Assets Total	306.5M	281.3M	350.2M	241.9M	238.3M	227.0M
Non Currrent Assets Other	(306.5M)	(281.3M)	(350.2M)	(241.9M)	(238.1M)	(250.0M)
Liabilities And Stockholders Equity	307.0M	286.5M	350.8M	248.7M	239.0M	229.2M
Total Current Assets	378.9K	5.1M	476K	6.7M	7.7M	8.1M
Short Term Debt	89.0K	0.0	68.5K	384.0	345.6	328.32
Common Stock	139.1M	131.3M	126.8M	125.1M	114.3M	107.0M
Non Current Liabilities Total	1.3M	44.3M	68.5K	3.5M	53.3M	56.0M
Capital Stock	206.1M	131.3M	126.8M	125.1M	114.3M	122.0M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

RSI	Rush Street Interactive
OKTA	Okta Inc
BAC	Bank of America

Additional Tools for Gabelli Stock Analysis

When running Gabelli Healthcare's price analysis, check to measure Gabelli Healthcare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Gabelli Healthcare is operating at the current time. Most of Gabelli Healthcare's value examination focuses on studying past and present price action to predict the probability of Gabelli Healthcare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Gabelli Healthcare's price. Additionally, you may evaluate how the addition of Gabelli Healthcare to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Gabelli Capex To Revenue vs Days Sales Outstanding Analysis

Capex To Revenue vs Days Sales Outstanding

Capex To Revenue vs Days Sales Outstanding Correlation Analysis

Correlation Coefficient

Capex To Revenue

Days Sales Outstanding

Gabelli Healthcare fundamental ratios Correlations

Gabelli Healthcare Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Gabelli Healthcare fundamental ratios Accounts

Also Currently Popular

Additional Tools for Gabelli Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Long Term Investments	+ 1.0	Total Assets
Cash And Short Term Investments	+ 1.0	Cash
Common Stock	+ 1.0	Common Stock Total Equity
Total Current Liabilities	+ 0.99	Accounts Payable
Capital Stock	+ 0.93	Common Stock
Capital Stock	+ 0.92	Common Stock Total Equity

Total Current Liabilities	- 1.0	Other Current Liab
Other Current Liab	- 0.99	Accounts Payable
Non Currrent Assets Other	- 0.98	Non Current Assets Total
Capital Stock	- 0.88	Short Long Term Debt Total
Cash And Short Term Investments	- 0.87	Other Current Liab
Other Current Liab	- 0.87	Cash